vs
Side-by-side financial comparison of IDEAYA Biosciences, Inc. (IDYA) and Trip.com Group Ltd (TCOM). Click either name above to swap in a different company.
Trip.com Group Ltd is the larger business by last-quarter revenue ($304.6M vs $207.8M, roughly 1.5× IDEAYA Biosciences, Inc.). IDEAYA Biosciences, Inc. runs the higher net margin — 57.4% vs 27.8%, a 29.6% gap on every dollar of revenue.
IDEAYA Biosciences, Inc. is a clinical-stage biotechnology company focused on oncology, developing targeted therapies and synthetic lethality treatments for patients with genetically defined cancers. It advances a pipeline of candidates across multiple tumor types, partnering with industry stakeholders to accelerate global access to innovative cancer care solutions.
Trip.com Group Limited is a multinational travel agency headquartered in Shanghai, China. It is the largest online travel service provider in the world.
IDYA vs TCOM — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $207.8M | $304.6M |
| Net Profit | $119.2M | $84.6M |
| Gross Margin | — | 78.8% |
| Operating Margin | 52.2% | 16.5% |
| Net Margin | 57.4% | 27.8% |
| Revenue YoY | — | — |
| Net Profit YoY | 330.1% | — |
| EPS (diluted) | $1.33 | $0.12 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $304.6M | ||
| Q3 25 | $207.8M | — | ||
| Q3 24 | $0 | — | ||
| Q2 24 | $0 | $242.7M | ||
| Q1 24 | $0 | — | ||
| Q2 23 | — | $214.5M | ||
| Q4 22 | — | $100.7M | ||
| Q3 22 | $29.7M | $82.7M |
| Q4 25 | — | $84.6M | ||
| Q3 25 | $119.2M | — | ||
| Q3 24 | $-51.8M | — | ||
| Q2 24 | $-52.8M | $73.8M | ||
| Q1 24 | $-39.6M | — | ||
| Q2 23 | — | $12.6M | ||
| Q4 22 | — | $41.5M | ||
| Q3 22 | $1.6M | $152.6M |
| Q4 25 | — | 78.8% | ||
| Q3 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 81.8% | ||
| Q1 24 | — | — | ||
| Q2 23 | — | 82.0% | ||
| Q4 22 | — | 76.0% | ||
| Q3 22 | — | 75.5% |
| Q4 25 | — | 16.5% | ||
| Q3 25 | 52.2% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 27.8% | ||
| Q1 24 | — | — | ||
| Q2 23 | — | 26.4% | ||
| Q4 22 | — | — | ||
| Q3 22 | 2.2% | -4.2% |
| Q4 25 | — | 27.8% | ||
| Q3 25 | 57.4% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 30.4% | ||
| Q1 24 | — | — | ||
| Q2 23 | — | 5.9% | ||
| Q4 22 | — | 41.2% | ||
| Q3 22 | 5.4% | 184.6% |
| Q4 25 | — | $0.12 | ||
| Q3 25 | $1.33 | — | ||
| Q3 24 | $-0.60 | — | ||
| Q2 24 | $-0.68 | $0.11 | ||
| Q1 24 | $-0.53 | — | ||
| Q2 23 | — | $0.02 | ||
| Q4 22 | — | $0.06 | ||
| Q3 22 | $0.04 | $0.00 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $786.9M | $10.8B |
| Total DebtLower is stronger | — | $4.2B |
| Stockholders' EquityBook value | $1.1B | $23.8B |
| Total Assets | $1.2B | $36.9B |
| Debt / EquityLower = less leverage | — | 0.18× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $10.8B | ||
| Q3 25 | $786.9M | — | ||
| Q3 24 | $920.0M | — | ||
| Q2 24 | $701.7M | $12.4B | ||
| Q1 24 | $698.8M | — | ||
| Q2 23 | — | $7.6B | ||
| Q4 22 | — | $6.2B | ||
| Q3 22 | $386.2M | $7.4B |
| Q4 25 | — | $4.2B | ||
| Q3 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $8.2B | ||
| Q1 24 | — | — | ||
| Q2 23 | — | $7.2B | ||
| Q4 22 | — | $1.8B | ||
| Q3 22 | — | $7.4B |
| Q4 25 | — | $23.8B | ||
| Q3 25 | $1.1B | — | ||
| Q3 24 | $1.2B | — | ||
| Q2 24 | $931.7M | $18.1B | ||
| Q1 24 | $935.3M | — | ||
| Q2 23 | — | $16.3B | ||
| Q4 22 | — | $16.3B | ||
| Q3 22 | $368.8M | $15.2B |
| Q4 25 | — | $36.9B | ||
| Q3 25 | $1.2B | — | ||
| Q3 24 | $1.2B | — | ||
| Q2 24 | $973.7M | $34.2B | ||
| Q1 24 | $961.5M | — | ||
| Q2 23 | — | $30.1B | ||
| Q4 22 | — | $27.8B | ||
| Q3 22 | $410.9M | $26.9B |
| Q4 25 | — | 0.18× | ||
| Q3 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.45× | ||
| Q1 24 | — | — | ||
| Q2 23 | — | 0.44× | ||
| Q4 22 | — | 0.11× | ||
| Q3 22 | — | 0.49× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $142.2M | — |
| Free Cash FlowOCF − Capex | $142.2M | — |
| FCF MarginFCF / Revenue | 68.4% | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | 1.19× | — |
| TTM Free Cash FlowTrailing 4 quarters | $13.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | $142.2M | — | ||
| Q3 24 | $-49.2M | — | ||
| Q2 24 | $-32.9M | — | ||
| Q1 24 | $-43.8M | — | ||
| Q2 23 | — | — | ||
| Q4 22 | — | $380.0M | ||
| Q3 22 | $-24.2M | — |
| Q4 25 | — | — | ||
| Q3 25 | $142.2M | — | ||
| Q3 24 | $-49.7M | — | ||
| Q2 24 | $-33.9M | — | ||
| Q1 24 | $-45.1M | — | ||
| Q2 23 | — | — | ||
| Q4 22 | — | $308.0M | ||
| Q3 22 | $-25.3M | — |
| Q4 25 | — | — | ||
| Q3 25 | 68.4% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q2 23 | — | — | ||
| Q4 22 | — | 305.7% | ||
| Q3 22 | -85.1% | — |
| Q4 25 | — | — | ||
| Q3 25 | 0.0% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q2 23 | — | — | ||
| Q4 22 | — | 71.5% | ||
| Q3 22 | 3.7% | — |
| Q4 25 | — | — | ||
| Q3 25 | 1.19× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q2 23 | — | — | ||
| Q4 22 | — | 9.15× | ||
| Q3 22 | -14.96× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IDYA
Segment breakdown not available.
TCOM
| Others | $273.0M | 90% |
| Other | $31.6M | 10% |
